T1	Pharmacological_substance 75 86	vincristine
N1000 	Reference T1 MeSH:D014750	vincristine
T2	Pharmacological_substance 88 98	adriamycin
N1001 	Reference T2 MeSH:D004317	adriamycin
T3	Pharmacological_substance 100 113	dexamethasone
N1002 	Reference T3 MeSH:D003907	dexamethasone
T4	Disorder 126 142	multiple myeloma
N1 	Reference T4 UMLS:C0026764	multiple myeloma
T5	Disorder 466 482	multiple myeloma
N2 	Reference T5 UMLS:C0026764	multiple myeloma
T6	Pharmacological_substance 530 541	vincristine
N1003 	Reference T6 MeSH:D014750	vincristine
T7	Pharmacological_substance 543 553	adriamycin
N1004 	Reference T7 MeSH:D004317	adriamycin
T8	Disorder 713 729	Muehrcke's lines
N3 	Reference T8 UMLS:C0263535	Muehrcke's lines
T9	Disorder 735 772	diffuse hyperpigmentation of the skin
N4 	Reference T9 UMLS:C0162834	diffuse hyperpigmentation of the skin
T10	Pharmacological_substance 1178 1189	vincristine
N1005 	Reference T10 MeSH:D014750	vincristine
T11	Disorder 144 169	Nail and skin alterations
T12	Subject 422 440	a 52-year-old male
T13	Pharmacological_substance 558 571	dexamathasone
N1006 	Reference T13 MeSH:D003907	dexamathasone
T15	Disorder 910 931	nail and skin changes
T17	Disorder 1049 1060	All changes
N5 	Reference T17 UMLS:C0600049	All changes
T18	Disorder 306 318	nail changes
N6 	Reference T18 UMLS:C0234909	nail changes
T19	Disorder 688 711	transverse melanonychia
N7 	Reference T19 UMLS:C3873518	transverse melanonychia
T23	Disorder 21 33	chromonychia
N8 	Reference T23 UMLS:C0221345	chromonychia
T24	Disorder 35 47	Beau's lines
N9 	Reference T24 UMLS:C0263534	Beau's lines
T25	Disorder 53 64	melanoderma
N10 	Reference T25 UMLS:C0221436	melanoderma
T27	Pharmacological_substance 197 209	chemotherapy
N1007 	Reference T27 MeSH:C403362	chemotherapy
N1008 	Reference T27 MeSH:D004113	chemotherapy
N1009 	Reference T27 MeSH:C057647	chemotherapy
T34	Disorder 674 686	Beau's lines
N11 	Reference T34 UMLS:C0263534	Beau's lines
T36	Pharmacological_substance 599 611	chemotherapy
N1010 	Reference T36 MeSH:C403362	chemotherapy
N1011 	Reference T36 MeSH:D004113	chemotherapy
N1012 	Reference T36 MeSH:C057647	chemotherapy
T37	Pharmacological_substance 981 1000	chemotherapy agents
N1013 	Reference T37 MeSH:D000970	chemotherapy agents
T41	Disorder 836 857	observed pigmentation
N12 	Reference T41 UMLS:C0478530	observed pigmentation
T42	Disorder 862 884	structural alterations
T46	Pharmacological_substance 1163 1173	adriamycin
N1014 	Reference T46 MeSH:D004317	adriamycin
T14	Pharmacological_substance 525 528	VAD
N1015 	Reference T14 MeSH:C041041	VAD
T16	Pharmacological_substance 1111 1114	VAD
N1016 	Reference T16 MeSH:C041041	VAD
T43	Speculation_cue 1193 1201	possible
